Challenges of the new EU clinical trial regulation EU 536/2014

• At: Seville (Spain) (2022)
• Type: Poster
• Poster code: HMI-028
• By: GLUšICA, Anja (Institute For Medicines And Medical Devices Of Montenegro, Montenegro)
• Co-author(s): Anja Glušica, Centre for medicines quality, safety and efficacy assessment (Institute For Medicines And Medical Devices Of Montenegro, Podgorica, Montenegro)
  Dr Snežana Mugoša, Managing Director (Institute For Medicines And Medical Devices Of Montenegro, Podgorica, Montenegro)
  Jelena Rakočević, Centre for medicines quality, safety and efficacy assessment (Institute For Medicines And Medical Devices Of Montenegro, Podgorica, Montenegro)
  
• Abstract:

  Introduction
  Clinical trials of drugs are essential in the development of new therapeutic solutions, and therefore it is necessary to establish such a regulatory framework which, in addition to promoting the rights and safety of subjects, also stimulates interest in conducting clinical trials. In response to the reduction of activities in the..

The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress. Please login